Qiagen N.V.

NYSE:QGEN

Medical - Diagnostics & Research

Healthcare
$49.56 -0.96%

-$0.35 today

Market cap
$10.23B
Beta
0.66
P/E (TTM)
18.6
EPS (TTM)
$1.94
Dividend yield
0.69%
52W Low $32.53High $57.82

Volume 4.26M

Average 2.07M

QGEN Total Debt

Short-term and long-term borrowings combined.

Qiagen N.V.NYSE: QGEN

Total Debt · Q2 FY2026 · quarter ended Jun 2026

Total debt rises 13.8% from a year ago

Total debt stood at $1.64B at the end of Q2 FY2026, up 13.8% from a year earlier and down 0.2% from the prior quarter. Over 3 fiscal years it compounded at -6.5% a year.

Context

  • Total debt amounted to 27.9% of total assets at the end of Q2 FY2026, up 3.1 pp from a year earlier.
  • Total debt increased in 1 of the last 3 fiscal years.

What to watch

Whether total debt keeps rising in the next quarterly balance sheet after a +13.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.64B-0.2% QoQ
Last fiscal yearDec 2025
$1.65B+2.8% YoY
Year agoJun 2025
$1.44B+13.8% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.8%——
1 year+2.8%——
3-year CAGR-6.5%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
1.65B USD
Year-over-year change
+2.8%
4-year CAGR
-6.0%

Total Debt vs competitors

How QGEN compares with its peers on the latest reported figures

  • QGEN's Jun 2026 total debt of $1.64B is the 6th highest of the 11 companies compared; the peer median is $1.56B.
  • Its year-over-year change of +13.8% is the 4th highest of 11, against a peer median of -7.7%.
  • Total debt amounts to 27.9% of total assets for QGEN, versus a peer median of 28.0%.
QGEN Competitors Peer median
Total Debt for QGEN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$41.37B +15.9%+3.0%36.2%
DHRDanaher CorporationSep 2026$26.48B +57.1%-3.7%28.4%
AAgilent Technologies, Inc.Jul 2026$3.95B +15.8%+6.6%28.3%
RVTYRevvity, Inc.Jul 2026$3.34B -1.0%-8.5%27.7%
BRKRBruker CorporationJun 2026$1.92B -21.3%+17.2%31.6%
QGENQiagen N.V.Jun 2026$1.64B +13.8%-6.5%27.9%
BIOBio-Rad Laboratories, Inc.Jun 2026$1.2B -14.4%+3.3%11.7%
RGENRepligen CorporationJun 2026$690.94M +0.7%+17.7%23.4%
TECHBio-Techne CorporationSep 2026$285.56M -27.6%-14.0%10.8%
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$176.7M -51.4%-60.7%29.3%
TXG10x Genomics, Inc.Sep 2026$75.79M -53.6%+18.3%7.1%
Peer median (excluding QGEN) $1.56B-7.7%+3.1%28.0%

Competitors are the stored peer set for QGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents880.52M730.67M668.08M663.56M839.01M
Short-term Investments184.79M687.6M389.7M489.44M259.91M
Net Receivables469.66M434.07M515.64M458.98M402.61M
Inventory327.53M357.96M398.39M279.26M301.89M
Other Current Assets186.48M132.7M130.9M26.85M191.66M
Total Current Assets2.11B2.39B2.15B1.96B2B
Property, Plant & Equipment (Net)638.18M662.17M765.04M753.61M923.95M
Goodwill2.35B2.35B2.48B2.43B2.7B
Intangible Assets627.44M544.8M526.82M303.82M386.43M
Long-term Investments00000
Tax Assets72.9M0000
Other Non-current Assets348.07M334.25M200.04M246.93M289.85M
Total Non-current Assets4.04B3.89B3.97B3.73B4.3B
Total Assets6.15B6.29B6.12B5.69B6.3B
Account Payables101.22M98.73M84.16M83.27M72.66M
Short-term Debt847.63M389.55M587.97M53.48M0
Tax Payables27.67M13.98M12.48M24.95M0
Deferred Revenue63.37M69M66.43M70.83M0
Other Current Liabilities257.65M192.19M118.03M113.21M0
Total Current Liabilities1.52B974.52M1.08B543.63M512.14M
Long-term Debt1.17B1.54B1B1.43B1.65B
Deferred Tax Liabilities37.59M17.5M12.8M22.7M0
Deferred Revenue (Non-current)11.3M15.2M15.7M18M0
Other Non-current Liabilities236.83M199.19M119.68M6.57M351.24M
Total Non-current Liabilities1.53B1.85B1.23B1.58B2.01B
Total Liabilities3.05B2.82B2.31B2.12B2.52B
Common Stock2.7M2.7M2.7M2.6M2.53M
Retained Earnings1.79B2.16B2.46B2.45B2.75B
Accumulated OCI(326.67M)(404.09M)(433.83M)(474.54M)(377.31M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.1B3.47B3.81B3.57B3.78B
Total Debt2.12B2.03B1.69B1.61B1.65B
Net Debt1.24B1.3B1.02B945.64M815.42M

Qiagen N.V.

NYSE:QGEN

Intrinsic Alpha fair value

Locked

Current Price

$49.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.